| Literature DB >> 24767789 |
Xuqiang Liu1, Xinhua Qu1, Chuanlong Wu1, Zanjing Zhai1, Bo Tian1, Haowei Li1, Zhengxiao Ouyang2, Xinchen Xu3, Wengang Wang1, Qiming Fan1, Tingting Tang1, An Qin4, Kerong Dai5.
Abstract
The aim of this study was to assess the effect of enoxacin on osteoclastogenesis and titanium particle-induced osteolysis. Wear particles liberated from the surface of prostheses are associated with aseptic prosthetic loosening. It is well established that wear particles induce inflammation, and that extensive osteoclastogenesis plays a critical role in peri-implant osteolysis and subsequent prosthetic loosening. Therefore, inhibiting extensive osteoclast formation and bone resorption could be a potential therapeutic target to prevent prosthetic loosening. In this study, we demonstrated that enoxacin, a fluoroquinolone antibiotic, exerts potent inhibitory effects on titanium particle-induced osteolysis in a mouse calvarial model. Interestingly, the number of mature osteoclasts decreased after treatment with enoxacin in vivo, suggesting that osteoclast formation might be inhibited by enoxacin. We then performed in vitro studies to confirm our hypothesis and revealed the mechanism of action of enoxacin. Enoxacin inhibited osteoclast formation by specifically abrogating RANKL-induced JNK signaling. Collectively, these results suggest that enoxacin, an antibiotic with few side effects that is widely used in clinics, had significant potential for the treatment of particle-induced peri-implant osteolysis and other diseases caused by excessive osteoclast formation and function.Entities:
Keywords: Enoxacin; JNK signaling; Osteoclasts; Osteolysis; Prosthetic loosening
Mesh:
Substances:
Year: 2014 PMID: 24767789 DOI: 10.1016/j.biomaterials.2014.04.006
Source DB: PubMed Journal: Biomaterials ISSN: 0142-9612 Impact factor: 12.479